Development of a communication protocol for telephone disclosure of genetic test results for cancer predisposition

JMIR Research Protocols

Volumn 3, Issue 4, 2014, Pages

  Patrick Miller, Linda J ^a   Egleston, Brian L ^b   Fetzer, Dominique ^c   Forman, Andrea ^b   Bealin, Lisa ^b   Rybak, Christina ^b   Peterson, Candace ^b   Corbman, Melanie ^b   Albarracin, Julio ^c   Stevens, Evelyn ^c   Daly, Mary B ^b   Bradbury, Angela R ^c  

^a SECTION OF HEMATOLOGY ONCOLOGY   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cancer risk assessment; Communication; Genetic testing; Self regulation theory of health behavior; Telemedicine; Test result disclosure

Indexed keywords

EID: 84947297078     PISSN: None     EISSN: 19290748     Source Type: Journal    
DOI: 10.2196/resprot.3337     Document Type: Article

References (85)

1. Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L. The continuum of translation research in genomic medicine: How can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med 2007 Oct; 9(10):665-674. [Medline: 18073579]
2. Burke W, Psaty BM. Personalized medicine in the era of genomics. JAMA 2007 Oct 10; 298(14):1682-1684. [doi: 10.1001/jama.298.14.1682] [Medline: 17925520]
3. Olopade OI, Grushko TA, Nanda R, Huo D. Advances in breast cancer: Pathways to personalized medicine. Clin Cancer Res 2008 Dec 15; 14(24):7988-7999 [FREE Full text] [doi: 10.1158/1078-0432.CCR-08-1211] [Medline: 19088015]
4. Schwartz GF, Hughes KS, Lynch HT, Fabian CJ, Fentiman IS, Robson ME, The International Consensus Conference Committee. Cancer. 2008 Nov 15 Presented at: International Consensus Conference on Breast Cancer Risk, Genetics, & Risk Management; April, 2007; Philadelphia p. 2627-2637. [doi: 10.1002/cncr.23903]
5. Robson ME, Storm CD, Weitzel J, Wollins DS, Offit K, American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: Genetic and genomic testing for cancer susceptibility. J Clin Oncol 2010 Feb 10; 28(5):893-901. [doi: 10.1200/JCO.2009.27.0660] [Medline: 20065170]
6. American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility. J Clin Oncol 2003 Jun 15; 21(12):2397-2406. [doi: 10.1200/JCO.2003.03.189] [Medline: 12692171]
7. U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Recommendation statement. Ann Intern Med 2005 Sep 6; 143(5):355-361. [Medline: 16144894]
8. Berliner JL, Fay AM, Practice Issues Subcommittee of the National Society of Genetic Counselors' Familial Cancer Risk Counseling Special Interest Group. Risk assessment and genetic counseling for hereditary breast and ovarian cancer: Recommendations of the National Society of Genetic Counselors. J Genet Couns 2007 Jun; 16(3):241-260. [doi: 10.1007/s10897-007-9090-7] [Medline: 17508274]
9. Ashley EA, Hershberger RE, Caleshu C, Ellinor PT, Garcia JG, Herrington DM, American Heart Association Advocacy Coordinating Committee. Genetics and cardiovascular disease: A policy statement from the American Heart Association. Circulation 2012 Jul 3; 126(1):142-157 [FREE Full text] [doi: 10.1161/CIR.0b013e31825b07f8] [Medline: 22645291]
10. Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Green RC, REVEAL (Risk Evaluation Education for Alzheimer's Disease) Study Group. Genetic risk assessment for adult children of people with Alzheimer's disease: The Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study. J Geriatr Psychiatry Neurol 2005 Dec; 18(4):250-255. [doi: 10.1177/0891988705281883] [Medline: 16306249]
11. Scheuner MT, Sieverding P, Shekelle PG. Delivery of genomic medicine for common chronic adult diseases: A systematic review. JAMA 2008 Mar 19; 299(11):1320-1334. [doi: 10.1001/jama.299.11.1320] [Medline: 18349093]
12. Khoury MJ, McBride CM, Schully SD, Ioannidis JP, Feero WG, Janssens AC, Centers for Disease Control and Prevention. The Scientific Foundation for personal genomics: Recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med 2009 Aug; 11(8):559-567 [FREE Full text] [doi: 10.1097/GIM.0b013e3181b13a6c] [Medline: 19617843]
13. Bloss CS, Jeste DV, Schork NJ. Genomics for disease treatment and prevention. Psychiatr Clin North Am 2011 Mar; 34(1):147-166 [FREE Full text] [doi: 10.1016/j.psc.2010.11.005] [Medline: 21333845]
14. Churpek JE, Onel K. Heritability of hematologic malignancies: From pedigrees to genomics. Hematol Oncol Clin North Am 2010 Oct; 24(5):939-972. [doi: 10.1016/j.hoc.2010.06.001] [Medline: 20816581]
15. Sivell S, Iredale R, Gray J, Coles B. Cancer genetic risk assessment for individuals at risk of familial breast cancer. Cochrane Database Syst Rev 2007(2):CD003721. [doi: 10.1002/14651858.CD003721.pub2] [Medline: 17443529]
16. McBride CM, Rimer BK. Using the telephone to improve health behavior and health service delivery. Patient Educ Couns 1999 May; 37(1):3-18. [Medline: 10640115]
17. Peshkin B, Demarco TA, Graves KD, Brown K, Nusbaum RH, Moglia D, et al. Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: Rationale and development of a randomized controlled trial. Genet Test 2008 Mar; 12(1):37-52. [doi: 10.1089/gte.2006.0525] [Medline: 18373403]
18. Biesecker BB, Boehnke M, Calzone K, Markel DS, Garber JE, Collins FS, et al. Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA 1993 Apr 21; 269(15):1970-1974. [Medline: 8352830]
19. Riley BD, Culver JO, Skrzynia C, Senter LA, Peters JA, Costalas JW, et al. Essential elements of genetic cancer risk assessment, counseling, and testing: Updated recommendations of the National Society of Genetic Counselors. J Genet Couns 2012 Apr; 21(2):151-161. [doi: 10.1007/s10897-011-9462-x] [Medline: 22134580]
20. Helmes AW, Culver JO, Bowen DJ. Results of a randomized study of telephone versus in-person breast cancer risk counseling. Patient Educ Couns 2006 Dec; 64(1-3):96-103. [doi: 10.1016/j.pec.2005.12.002] [Medline: 16427245]
21. Ormond KE, Haun J, Cook L, Duquette D, Ludowese C, Matthews AL. Recommendations for Telephone Counseling. Journal of Genetic Counseling 2000 Feb 01; 9(1):63-71. [doi: 10.1023/A:1009433224504]
22. Coelho JJ, Arnold A, Nayler J, Tischkowitz M, MacKay J. An assessment of the efficacy of cancer genetic counselling using real-time videoconferencing technology (telemedicine) compared to face-to-face consultations. Eur J Cancer 2005 Oct; 41(15):2257-2261. [doi: 10.1016/j.ejca.2005.06.020] [Medline: 16176873]
23. Sturm AC, Hershberger RE. Genetic testing in cardiovascular medicine: Current landscape and future horizons. Curr Opin Cardiol 2013 May; 28(3):317-325. [doi: 10.1097/HCO.0b013e32835fb728] [Medline: 23571470]
24. Chen WY, Garber JE, Higham S, Schneider KA, Davis KB, Deffenbaugh AM, et al. BRCA1/2 genetic testing in the community setting. J Clin Oncol 2002 Nov 15; 20(22):4485-4492. [Medline: 12431973]
25. Bradbury AR, Patrick-Miller L, Fetzer D, Egleston B, Cummings SA, Forman A, et al. Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results. Clin Genet 2011 Feb; 79(2):125-131 [FREE Full text] [doi: 10.1111/j.1399-0004.2010.01540.x] [Medline: 21039431]
26. Doughty Rice C, Ruschman JG, Martin LJ, Manders JB, Miller E. Retrospective comparison of patient outcomes after in-person and telephone results disclosure counseling for BRCA1/2 genetic testing. Fam Cancer 2010 Jun; 9(2):203-212. [doi: 10.1007/s10689-009-9303-3] [Medline: 20473602]
27. Baumanis L, Evans JP, Callanan N, Susswein LR. Telephoned BRCA1/2 genetic test results: Prevalence, practice, and patient satisfaction. J Genet Couns 2009 Oct; 18(5):447-463. [doi: 10.1007/s10897-009-9238-8] [Medline: 19462222]
28. Schwartz MD, Lerman C, Brogan B, Peshkin BN, Halbert CH, DeMarco T, et al. Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol 2004 May 15; 22(10):1823-1829. [doi: 10.1200/JCO.2004.04.086] [Medline: 15067026]
29. Christensen KD, Roberts JS, Shalowitz DI, Everett JN, Kim SY, Raskin L, et al. Disclosing individual CDKN2A research results to melanoma survivors: Interest, impact, and demands on researchers. Cancer Epidemiol Biomarkers Prev 2011 Mar; 20(3):522-529 [FREE Full text] [doi: 10.1158/1055-9965.EPI-10-1045] [Medline: 21307304]
30. Geransar R, Einsiedel E. Evaluating online direct-to-consumer marketing of genetic tests: Informed choices or buyers beware? Genet Test 2008 Mar; 12(1):13-23. [doi: 10.1089/gte.2007.0024] [Medline: 18373401]
31. Schwartz MD, Valdimarsdottir HB, Peshkin BN, Mandelblatt J, Nusbaum R, Huang AT, et al. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. J Clin Oncol 2014 Mar 1; 32(7):618-626. [doi: 10.1200/JCO.2013.51.3226] [Medline: 24449235]
32. Informed DNA. URL: http://www.informeddna.com/[WebCite Cache ID 6S01SREhk]
33. Genetic Counseling Services. URL: http://www.geneticcounselingservices.com/[WebCite Cache ID 6S01UJMki]
34. Patrick-Miller L, Egleston BL, Daly M, Stevens E, Fetzer D, Forman A, et al. Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results. Patient Educ Couns 2013 Dec; 93(3):413-419. [doi: 10.1016/j.pec.2013.08.009] [Medline: 24075727]
35. Domchek SM, Bradbury A, Garber JE, Offit K, Robson ME. Multiplex genetic testing for cancer susceptibility: Out on the high wire without a net? J Clin Oncol 2013 Apr 1; 31(10):1267-1270. [doi: 10.1200/JCO.2012.46.9403] [Medline: 23460708]
36. Croyle RT, Lerman C. Risk communication in genetic testing for cancer susceptibility. J Natl Cancer Inst Monogr 1999(25):59-66. [Medline: 10854459]
37. Department of Health and Human Services. Dissemination and Implementation Research in Health (R01)URL: http://grants. nih.gov/grants/guide/pa-files/PAR-10-038.html[WebCite Cache ID 6S01anszA]
38. Hesse BW, Arora NK, Khoury MJ. Implications of Internet availability of genomic information for public health practice. Public Health Genomics 2012; 15(3-4):201-208 [FREE Full text] [doi: 10.1159/000335892] [Medline: 22488463]
39. Leventhal H, Benyamini Y, Brownlee S, Diefenbach M, Leventhal EA, Patrick-Miller L, et al. Perceptions of health illness: Current research applications. In: Petrie KJ, Weinman JA, editors. Illness Representations: Theoretical Foundations. The Netherlands: Harwood Academic Pub; Jul 01, 1997:19-46.
40. Kelly K, Leventhal H, Andrykowski M, Toppmeyer D, Much J, Dermody J, et al. Using the common sense model to understand perceived cancer risk in individuals testing for BRCA1/2 mutations. Psychooncology 2005 Jan; 14(1):34-48. [doi: 10.1002/pon.805] [Medline: 15386791]
41. Innes M, Skelton J, Greenfield S. A profile of communication in primary care physician telephone consultations: Application of the Roter Interaction Analysis System. Br J Gen Pract 2006 May; 56(526):363-368 [FREE Full text] [Medline: 16638252]
42. Shiloh S. Illness representations, self-regulation, and genetic counseling: A theoretical review. J Genet Couns 2006 Oct; 15(5):325-337. [doi: 10.1007/s10897-006-9044-5] [Medline: 16972194]
43. Shiloh S, Drori E, Orr-Urtreger A, Friedman E. Being 'at-risk' for developing cancer: Cognitive representations and psychological outcomes. J Behav Med 2009 Apr; 32(2):197-208. [doi: 10.1007/s10865-008-9178-z] [Medline: 18807164]
44. Communicating genetic test results by telephone: A randomized trial. 5R01CA160847-02 (PI: Bradbury)URL: http://projectreporter.nih.gov/project_info_description. cfm?aid=8513942 & icde=17523231 & ddparam= & ddvalue= & ddsub= & cr=1 & csb=default & cs=ASC
45. Virtual cancer genetic services: Telemedicine delivery in community clinics. 1R21CA164121-01A1 (PI: Bradbury)URL: http://projectreporter.nih.gov/project[WebCite Cache ID 6S02PbD5g]
46. Burke W, Khoury MJ, Stewart A, Zimmern RL, Bellagio Group. The path from genome-based research to population health: Development of an international public health genomics network. Genet Med 2006 Jul; 8(7):451-458. [Medline: 16845279]
47. Burgess MM. Beyond consent: Ethical and social issues in genetic testing. Nat Rev Genet 2001 Feb; 2(2):147-151. [doi: 10.1038/35052579] [Medline: 11253055]
48. Cameron L, Leventhal EA, Leventhal H. Symptom representations and affect as determinants of care seeking in a community-dwelling, adult sample population. Health Psychol 1993 May; 12(3):171-179. [Medline: 8500446]
49. Patrick-Miller L, Kelly K, Toppmeyer D, Leventhal H, Much J, Baron J, et al. Breast cancer screening behaviors and perceived control in individuals interested in testing for BRCA1/2 mutations. American Society of Clinical Oncology 2001; Abstract.
50. Weinman J, Petrie KJ, Sharpe N, Walker S. Causal attributions in patients and spouses following first-time myocardial infarction and subsequent lifestyle changes. British Journal of Health Psychology 2000; 5:263-273. [doi: 10.1348/135910700168900]
51. Zimmerman RS, Safer MA, Leventhal H, Baumann LJ. The effects of health information in a worksite hypertension screening program. Health Educ Q 1986; 13(3):261-280. [Medline: 3759479]
52. Park DC. Self-regulation and control of rheumatic disorders. In: Maes S, Leventhal H, Johnston MC, editors. International Review of Health Psychology, Volume 3. Chichester, England: John Wiley & Sons; 1994.
53. Kelly KM, Ferketich AK, Sturm AC, Porter K, Sweet K, Kemp K, et al. Cancer risk and risk communication in urban, lower-income neighborhoods. Prev Med 2009 Apr; 48(4):392-396. [doi: 10.1016/j.ypmed.2009.01.009] [Medline: 19463493]
54. Acheson LS, Crabtree BF. How do people interpret their family histories of diabetes, coronary disease, or cancer? Ann Fam Med 2004; 2(6):532-533 [FREE Full text] [doi: 10.1370/afm.247] [Medline: 15576536]
55. Rees G, Fry A, Cull A. A family history of breast cancer: women's experiences from a theoretical perspective. Soc Sci Med 2001 May; 52(9):1433-1440. [Medline: 11286366]
56. Patrick-Miller L, Bradbury AR, Terry MB. Controversies in communication of genetic screening results for cancer: A report from the American Society of Preventive Oncology's Screening Special Interest Group (ASPO's 33rd Annual Meeting, March 8 to 10, 2009, Tampa, Florida). Cancer Epidemiol Biomarkers Prev 2010 Feb; 19(2):624-627 [FREE Full text] [doi: 10.1158/1055-9965.EPI-19-2-ASPO01] [Medline: 20142257]
57. Hamilton JG, Lobel M, Moyer A. Emotional distress following genetic testing for hereditary breast and ovarian cancer: A meta-analytic review. Health Psychol 2009 Jul; 28(4):510-518 [FREE Full text] [doi: 10.1037/a0014778] [Medline: 19594276]
58. O'Neill SC, Rini C, Goldsmith R, Valdimarsdottir H, Cohen LH, Schwartz MD. Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes. Psychooncology 2009 Oct; 18(10):1088-1096 [FREE Full text] [doi: 10.1002/pon.1467] [Medline: 19214961]
59. Lynch HT, Snyder C, Lynch JF, Karatoprakli P, Trowonou A, Metcalfe K, et al. Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families. Cancer Genet Cytogenet 2006 Mar; 165(2):91-97. [doi: 10.1016/j.cancergencyto.2005.07.011] [Medline: 16527602]
60. Schlich-Bakker KJ, ten Kroode HF, Ausems MG. A literature review of the psychological impact of genetic testing on breast cancer patients. Patient Educ Couns 2006 Jul; 62(1):13-20. [doi: 10.1016/j.pec.2005.08.012] [Medline: 16242293]
61. Halbert C, Kessler L, Collier A, Paul Wileyto E, Brewster K, Weathers B. Psychological functioning in African American women at an increased risk of hereditary breast and ovarian cancer. Clin Genet 2005 Sep; 68(3):222-227. [doi: 10.1111/j.1399-0004.2005.00483.x] [Medline: 16098010]
62. Kinney AY, Bloor LE, Mandal D, Simonsen SE, Baty BJ, Holubkov R, et al. The impact of receiving genetic test results on general and cancer-specific psychologic distress among members of an African-American kindred with a BRCA1 mutation. Cancer 2005 Dec 1; 104(11):2508-2516 [FREE Full text] [doi: 10.1002/cncr.21479] [Medline: 16222692]
63. Kinney AY, Simonsen SE, Baty BJ, Mandal D, Neuhausen SL, Seggar K, et al. Risk reduction behaviors and provider communication following genetic counseling and BRCA1 mutation testing in an African American kindred. J Genet Couns 2006 Aug; 15(4):293-305. [doi: 10.1007/s10897-006-9026-7] [Medline: 16865561]
64. Jenkins J, Calzone KA, Dimond E, Liewehr DJ, Steinberg SM, Jourkiv O, et al. Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling. Genet Med 2007 Aug; 9(8):487-495. [Medline: 17700386]
65. Weitzel J, Blazer KR, Macdonald DJ, Culver JO, Offit K. Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine. CA Cancer J Clin 2011 Aug 19; 61(5) [FREE Full text] [doi: 10.3322/caac.20128] [Medline: 21858794]
66. McKinstry B, Hammersley V, Burton C, Pinnock H, Elton R, Dowell J, et al. The quality, safety and content of telephone and face-to-face consultations: A comparative study. Qual Saf Health Care 2010 Aug; 19(4):298-303. [doi: 10.1136/qshc.2008.027763] [Medline: 20430933]
67. Ubel PA. Critical Decisions: How You and Your Doctor Can Make the Right Medical Choices Together. New York: HarperOne; Sep 04, 2012.
68. Kelly K, Leventhal H, Marvin M, Toppmeyer D, Baran J, Schwalb M. Cancer genetics knowledge and beliefs and receipt of results in Ashkenazi Jewish individuals receiving counseling for BRCA1/2 mutations. Cancer Control 2004; 11(4):236-244 [FREE Full text] [Medline: 15284715]
69. American College of Medical Genetics. Statement on population screening for BRCA-1 mutation in Ashkenazi Jewish women. 1996. URL: https://www.acmg.net/StaticContent/StaticPages/Ashkenazi.pdf[WebCite Cache ID 6S04XNoFq]
70. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA 1996 Jun 26; 275(24):1885-1892. [Medline: 8648868]
71. Speilberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1983.
72. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983 Jun; 67(6):361-370. [Medline: 6880820]
73. Pieterse AH, van Dulmen AM, Beemer FA, Bensing JM, Ausems MG. Cancer genetic counseling: Communication and counselees' post-visit satisfaction, cognitions, anxiety, and needs fulfillment. J Genet Couns 2007 Feb; 16(1):85-96 [FREE Full text] [doi: 10.1007/s10897-006-9048-1] [Medline: 17295054]
74. DeMarco TA, Peshkin BN, Mars BD, Tercyak KP. Patient satisfaction with cancer genetic counseling: A psychometric analysis of the Genetic Counseling Satisfaction Scale. J Genet Couns 2004 Aug; 13(4):293-304 [FREE Full text] [Medline: 19736695]
75. Cella D, Hughes C, Peterman A, Chang CH, Peshkin BN, Schwartz MD, et al. A brief assessment of concerns associated with genetic testing for cancer: The Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychol 2002 Nov; 21(6):564-572. [Medline: 12433008]
76. Braithwaite D, Emery J, Walter F, Prevost AT, Sutton S. Psychological impact of genetic counseling for familial cancer: A systematic review and meta-analysis. Fam Cancer 2006; 5(1):61-75. [doi: 10.1007/s10689-005-2577-1] [Medline: 16528610]
77. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002 Feb; 52(2):69-77. [Medline: 11832252]
78. Armstrong K, Micco E, Carney A, Stopfer J, Putt M. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA 2005 Apr 13; 293(14):1729-1736. [doi: 10.1001/jama.293.14.1729] [Medline: 15827311]
79. Lea DH, Johnson JL, Ellingwood S, Allan W, Patel A, Smith R. Telegenetics in Maine: Successful clinical and educational service delivery model developed from a 3-year pilot project. Genet Med 2005 Jan; 7(1):21-27. [Medline: 15654224]
80. Godard B, Pratte A, Dumont M, Simard-Lebrun A, Simard J. Factors associated with an individual's decision to withdraw from genetic testing for breast and ovarian cancer susceptibility: Implications for counseling. Genet Test 2007; 11(1):45-54. [doi: 10.1089/gte.2006.9998] [Medline: 17394392]
81. Curtis P. The telephone interview. In: Reisman AB, Stevens DL, editors. Telephone Medicine: A Guide for the Practicing Physician. Philadelphia: American College of Physician-American Society of Internal Medicine; 2002.
82. Silverman J, Kurtz SM, Draper J. Skills For Communicating With Patients. Alberta: Radcliffe Medical Press; 1998.
83. Platten U, Rantala J, Lindblom A, Brandberg Y, Lindgren G, Arver B. The use of telephone in genetic counseling versus in-person counseling: A randomized study on counselees' outcome. Fam Cancer 2012 Sep; 11(3):371-379 [FREE Full text] [doi: 10.1007/s10689-012-9522-x] [Medline: 22399327]
84. Mackenzie A, Patrick-Miller L, Bradbury AR. Controversies in communication of genetic risk for hereditary breast cancer. Breast J 2009; 15 Suppl 1:S25-S32. [doi: 10.1111/j.1524-4741.2009.00800.x] [Medline: 19775327]
85. Ngo-Metzger Q, Hayes GR, Yunan Chen, Cygan R, Garfield CF. Improving communication between patients and providers using health information technology and other quality improvement strategies: Focus on low-income children. Med Care Res Rev 2010 Oct; 67(5 Suppl):246S-267S. [doi: 10.1177/1077558710375431] [Medline: 20675346]